IFNG and COVID-19: Different works validated a whole-blood test based on IFN-γ release for the detection of a SARS-CoV-2 specific T-cell response to discriminate COVID-19 patients from uninfected individuals, and to monitor the immune response in vaccinated individuals (13, 36–40).